Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application
Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application
Stay updated with breaking news from Senping Cheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Triastek's 3D Printed Gastric Retention Product T22 Receives FDA Clearance of IND Application
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Triastek Inc., a healthcare leader with a global footprint, recently achieved a significant milestone by clinching the 2023 TCT Healthcare Application Award.
The FDA gives clinical trial clearance to 3D-printed colon-targeted oral drug for ulcerative colitis to improve safety of the dosage release.
/PRNewswire/ -- Triastek, Inc. ("Triastek") a global healthcare company pioneering 3D printing of pharmaceuticals with its proprietary technology, Melt...